Robert Celeste, director of healthcare with GS1US, relates the group's efforts in establishing industry-wide standards for the life sciences sector.

Wayne McDonnell, director of pharma and life sciences advisory with PricewaterhouseCoopers, talks about the core fundamentals of supply-chain capabilities today, as well as PwC's latest "Pharma 2020" report.

When innovation comes to mind, the first thing people might think of is creativity, spontaneity or a momentary stroke of genius. But can innovation occur out of a structured, repeatable process? The answer, in short, is yes.